Authors
Chuvinova I. V.
PhD (Pedagogics), Assistant Professor, Chair for Medical Biology1
Belova V. V.
Senior laboratory assistant, Chair for Medical Biology1
1 - Tambov State University named after G.R. Derzhavin, Tambov, Russian Federation
Corresponding Author
Belova Valeria; e-mail: vuz.lera@yandex.ru
Conflict of interest
None declared.
Funding
The study had no sponsorship.
Abstract
Introduction. Due to the pandemic of highly detailed mycosis caused by Candida auris, there is a need for a comprehensive study of the pathogen. The active spread of the infection began after 2016 (initially, this representative of the genus Candida was discovered in 1996 in South Korea). This species is found on all continents except Antarctica, and under a number of conditions can be the cause of an opportunistic infection. The purpose of this work is to identify the factors causing the high pathogenic potential of Candida auris and to give an idea of the main measures preventing the spread of mycosis caused by this pathogen. Materials and methods. The type of research is a literature review. The search for scientific information was carried out in the following databases: scientific electronic library eLibrary.RU, PubMed (database created by the National Center for Biotechnology Information (NCBI) USA). The review included publications on the research topic that were published mainly over the past 4 years. The results of the study. Up-to-date information has been obtained in the field of morphology, metabolism and genetics of Candida auris. Based on it, significant differences between Candida auris and other species have been identified, increasing survival rates in adverse abiotic conditions and pathogenicity, as well as contributing to the growth of antibiotic resistance. Conclusion. According to the results of the study, Candida auris has the highest pathogenicity among all other representatives of the genus, which makes it necessary to strengthen measures preventing the spread of mycosis caused by this pathogen in medical institutions. Modern methods of laboratory diagnosis of this infection should also be introduced.
Key words
candidiasis, antibiotic resistance, pathogenicity, risk factors, preventive measures
DOI
References
1. Vorob'yev A.A., Krivoshein Yu.S., Shirobokov V.P. Meditsinskaya i sanitarnaya mikrobiologiya: uchebnoye posobiye dlya studentov vysshikh meditsinskikh uchebnykh zavedeniy [Medical and sanitary microbiology: a textbook for students of higher medical educational institutions.] Moscow: Publishing center «Academia», 2003. (In Russ.)
2. Ivanov A.A., Kulichenko T.V. Candida auris: problemy diagnostiki i lecheniya. [Candida auris: problems of diagnosis and treatment. Issues of modern pediatrics.] Voprosy sovremennoy pediatrii [Issues of modern pediatrics] 2020; 19(1): 20-25, doi: 10.15690/vsp.v19i1.2081. (In Russ.)
3. Kol'tsov I.P., Strel'nikova N.V., Vit'ko Ye.V., et al. Mikrobiologicheskiye svoystva uslovno-patogennykh sakharomitsetov roda Candida pri khronicheskikh, retsidiviruyushchikh infektsionno-vospalitel'nykh protsessakh (obzor literatury) [Microbiological properties of conditionally pathogenic saccharomycetes of the genus Candida in chronic, recurrent infectious and inflammatory processes (literature review).] Tikhookeanskiy meditsinskiy zhurnal [Pacific Medical Journal] 2023; 1(91): 19-26, doi: 10.34215/1609-1175-2023-1-19-26. (In Russ.)
4. Khaytovich A.B., Kravchenko A.N., Yakovleva Ye.V. Candida auris kak prichina zabolevaniya u lyudey [Candida auris as a cause of disease in humans.] Fundamental'nyye i prikladnyye issledovaniya v sovremennom mire [Fundamental and applied research in the modern world] 2021; 3(29): 7-17. (In Russ.)
5. Khaytovich A.B., Yakovleva Ye.V. Candida auris kak prichina vnutribol'nichnykh infektsiy [Candida auris as a cause of nosocomial infections.] Uspekhi meditsinskoy mikologii [Advances in medical mycology] 2020; 21: 258-266. (In Russ.)
6. Barantsevich N.Ye., Levanova V.V., Barantsevich Ye.P. Regional'nyye osobennosti rasprostraneniya Candida auris [Regional features of the spread of Candida auris.] Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya [Clinical microbiology and antimicrobial chemotherapy] 2021; 23(2): 117-125, doi: 10.36488/cmac.2021.2.117-125. (In Russ.)
7. Yenoktayeva O.V., Nikolenko M.V., Yermakova A.A. Biologicheskiye svoystva Candida auris [Biological properties of Candida auris.] Uspekhi meditsinskoy mikologii [Advances in medical mycology] 2022; 23: 120-123. (In Russ.)
8. Zverev V.V., Boychenko M.N. Meditsinskaya mikrobiologiya, virusologiya i immunologiya. V 2-kh tomakh. Tom 2. uchebnoye posobiye po distsipline «Mikrobiologiya, virusologiya i immunologiya» dlya studentov uchrezhdeniy vysshego professional'nogo obrazovaniya, obuchayushchikhsya po spetsial'nostyam 060101.65 «Lechebnoye delo», 060103.65 «Pediatriya», 060104.65 «Mediko-profilakticheskoye delo» [Medical microbiology, virology and immunology. In 2 volumes. Volume 2.] Moscow: GEOTAR-Media, 2010. (In Russ.)
9. Vasil'yeva N.V., Stepanova A.A., Kruglov A.N., et al. Skaniruyushchaya elektronnaya mikroskopiya drozhzhevykh kletok Candida auris [Scanning electron microscopy of Candida auris yeast cells.] Problemy meditsinskoy mikologii [Problems of medical mycology]. 2020; 22(1): 52-57, doi: 10.24412/1999-6780-2020-1-52-57. (In Russ.)
10. Vasil'yeva N.V., Kruglov A.N., Stepanova A.A., et al. Tsitologicheskiye osobennosti drozhzhevykh kletok mul'tirezistentnogo patogena Candida auris [Cytological features of yeast cells of the multidrug-resistant pathogen Candida auris.] Problemy meditsinskoy mikologii [Problems of medical mycology] 2018; 20(3): 3-7. (In Russ.)
11. Garcia-Rubio R., de Oliveira H.C., Rivera J., Trevijano-Contador N. The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species. Front Microbiol. 2020; 10: 2993, doi: 10.3389/fmicb.2019.02993
12. Kumar M., Singh A., Kumari S., et al. Sphingolipidomics of drug-resistant Candida auris clinical isolates reveal distinct sphingolipid species signatures. Biochim Biophys Acta Mol Cell Biol Lipids. 2021; 1866(1): 158815, doi: 10.1016/j.bbalip.2020.158815
13. Shahi G., Kumar M., Skwarecki A.S., et al. Fluconazole resistant Candida auris clinical isolates have increased levels of cell wall chitin and increased susceptibility to a glucosamine-6-phosphate synthase inhibitor. Cell Surf. 2022; 8: 100076, doi: 10.1016/j.tcsw.2022.100076
14. Aleksandrova N.A., Zaslavskaya M.I., Ignatova N.I., Makhrova T.V. Sravnitel'naya kharakteristika patogennogo potentsiala Candida albicans i Candida auris [Comparative characteristics of the pathogenic potential of Candida albicans and Candida auris.] Problemy meditsinskoy mikologii [Problems of medical mycology]. 2023; 25(2): 80. (In Russ.)
15. Brandt P., Mirhakkak M.H., Wagner L., et al. High-Throughput Profiling of Candida auris Isolates Reveals Clade-Specific Metabolic Differences. Microbiol Spectr. 2023; 11(3): e0049823, doi: 10.1128/spectrum.00498-23
16. Horton M.V., Johnson C.J., Zarnowski R., et al. Candida auris Cell Wall Mannosylation Contributes to Neutrophil Evasion through Pathways Divergent from Candida albicans and Candida glabrata. mSphere 2021; 6(3): e0040621, doi:10.1128/mSphere.00406-21
17. Du H., Bing J., Hu T., Ennis C.L, Nobile C.J., Huang G. Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020; 16(10): e1008921, doi: 10.1371/journal.ppat.1008921
18. Rowan N.J., Anderson J.G. Effects of above-optimum growth temperature and cell morphology on thermotolerance of Listeria monocytogenes cells suspended in bovine milk. Appl Environ Microbiol. 1998; 64(6): 2065-2071, doi: 10.1128/AEM.64.6.2065-2071.1998
19. Fel'ker I.G., Gordeyeva Ye.I., Stavitskaya N.V., et al. Perspektivy i prepyatstviya dlya klinicheskogo primeneniya ingibitorov efflyuksnykh pomp Mycobacterium tuberculosis [Prospects and obstacles for the clinical use of Mycobacterium tuberculosis efflux pump inhibitors.] Biologicheskiye membrany [Biological membranes] 2021; 38(5): 317-339, doi: 10.31857/S0233475521050054. (In Russ.)
20. Khatoon R., Sharma S., Prasad R., Lynn A.M., Prakash A., Banerjee A. Genome-wide analysis of PTR transporters in Candida species and their functional characterization in Candida auris. Appl Microbiol Biotechnol. 2022; 106(11): 4223-4235, doi: 10.1007/s00253-022-11998-9
21. Ignatova N.I., Zaslavskaya M.I., Aleksandrova N.A., et al. Sravnitel'naya otsenka fermentativnoy i biotsidnoy aktivnosti Candida auris i Candida albicans [Comparative assessment of the enzymatic and biocidal activity of Candida aureus and Candida albicans.] Zhurnal mikrobiologii, epidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology] 2023; 100(3): 203-209. doi: 10.36233/0372-9311-301. (In Russ.)